This is additionally underpinned by the fact that the new diagnostic method developed by Zhang et al., based on contrast-enhanced computed tomography (CECT) combined with liposome-encapsulated targeted contrast agents containing tyrosine kinase inhibitors of GC, including RET, allowed for the effective diagnosis of patients in the early stage of gastric cancer 53. This evidence concerns the gene RET and gastric cancer.